Autori: Correll Christoph U
| Naslov | Benefits and safety of brexpiprazole in adolescents living with schizophrenia: a plain language summary (Editorial Material; Early Access) |
| Autori | Ward Caroline Pejovic-Milovancevic Milica M Hefting Nanco Chen Dalei Larsen Klaus Groes Hobart Mary Correll Christoph U |
| Info | CURRENT MEDICAL RESEARCH AND OPINION, (2026), vol. br. , str. - |
| Projekat | Otsuka Pharmaceutical Development & Commercialization Inc.; H Lundbeck A/S |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: |
| Naslov | Efficacy and safety of brexpiprazole in adolescents with schizophrenia: a multicountry, randomised, double-blind, placebo-controlled, phase 3 trial with an active reference (Article) |
| Autori | Ward Caroline Pejovic-Milovancevic Milica M Kohegyi Eva Hefting Nanco Aurang Catherine Chen Dalei Larsen Klaus Groes Hobart Mary Correll Christoph U |
| Info | LANCET PSYCHIATRY, (2025), vol. 12 br. 5, str. 345-354 |
| Projekat | Otsuka Pharmaceutical Development & Commercialization; H Lundbeck |
| Ispravka | ISI/Web of Science Članak Citati: ISI/Web of Science |
| Naslov | Treatment Approaches for First Episode and Early-Phase Schizophrenia in Adolescents and Young Adults: A Delphi Consensus Report from Europe (Article) |
| Autori | Correll Christoph U Fusar-Poli Paolo Leucht Stefan Karow Anne Maric Nadja P Moreno Carmen Nordentoft Merete Raballo Andrea |
| Info | NEUROPSYCHIATRIC DISEASE AND TREATMENT, (2022), vol. 18 br. , str. 201-219 |
| Projekat | Angelini Pharma |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
